Innate Pharma SA Cash Flows From Used In Investing Activities
Innate Pharma SA (IPHA) reported Cash Flows From Used In Investing Activities of EUR 7.29 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Cash Flow › Investing Activities
ifrs-full:CashFlowsFromUsedInInvestingActivities · last filed 2026-04-01
| Period end | Cash Flows From Used In Investing Activities 6 month | Cash Flows From Used In Investing Activities 12 month | Cash Flows From Used In Investing Activities 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | 7.29M EUR 20-F · filed 2026-04-01 | ||
| 2025-06-30 | 6.97M EUR 6-K · filed 2025-09-17 | ||
| 2024-12-31 | 9.20M EUR 20-F · filed 2026-04-01 | ||
| 2024-06-30 | 932.00K EUR 6-K · filed 2025-09-17 | ||
| 2023-12-31 | 20.63M EUR 20-F · filed 2026-04-01 | 20.63M EUR 20-F · filed 2024-04-04 | |
| 2023-06-30 | -246.00K EUR 6-K · filed 2024-09-12 | ||
| 2022-12-31 | 1.88M EUR 20-F · filed 2025-04-30 | ||
| 2022-06-30 | -395.00K EUR 6-K · filed 2023-09-14 | ||
| 2021-12-31 | -917.00K EUR 20-F · filed 2024-04-04 | ||
| 2021-06-30 | -247.00K EUR 6-K · filed 2022-09-15 | ||
| 2020-12-31 | -13.37M EUR 20-F · filed 2023-04-06 | ||
| 2020-06-30 | -12.11M EUR 6-K · filed 2021-09-15 | ||
| 2019-12-31 | -62.12M EUR 20-F · filed 2022-04-04 | ||
| 2018-12-31 | 24.28M EUR 20-F · filed 2021-04-27 | ||
| 2017-12-31 | -29.46M EUR 20-F · filed 2020-04-24 |